Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Frye

Showing results (201-210 of 518) with videos related to

Pageof 52
Sort By:
The Journal of Clinical Psychiatry|January 2, 2007
Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trialsMark A Frye, Lakshmi N Yatham, Joseph R Calabrese, et al.
The Journal of Clinical Psychiatry|August 20, 2009
Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placeboJoseph F Goldberg, Joseph R Calabrese, Benjamin R Saville, et al.
Elife|March 23, 2021
A visual pathway for skylight polarization processing in <i>Drosophila</i>Ben J Hardcastle, Jaison J Omoto, Pratyush Kandimalla, et al.
Journal of Clinical Psychopharmacology|January 13, 2025
Clinical and Demographic Predictors of Early Clozapine Discontinuation Across Mood and Psychotic DisordersMete Ercis, Kristin C Cole, Ross A Dierkhising, et al.
Biological Psychiatry|January 28, 2003
Low CSF somatostatin associated with response to nimodipine in patents with affective illnessMark A Frye, Peggy J Pazzaglia, Mark S George, et al.
Brain and Behavior|May 31, 2021
Self-report screening instruments differentiate bipolar disorder and borderline personality disorderBrian A Palmer, Mehak Pahwa, Jennifer R Geske, et al.
International Journal of Bipolar Disorders|October 5, 2019
Treatment of bipolar depression with supraphysiologic doses of levothyroxine: a randomized, placebo-controlled study of comorbid anxiety symptomsMaximilian Pilhatsch, Thomas J Stamm, Petra Stahl, et al.
Biological Psychiatry|June 5, 2007
Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorderJoseph F Goldberg, Charles L Bowden, Joseph R Calabrese, et al.
Journal of Psychiatric Research|July 10, 2023
Prevalence and outcomes of rapid cycling bipolar disorder: Mixed method systematic meta-reviewAlessandro Miola, Konstantinos N Fountoulakis, Ross J Baldessarini, et al.
Focus (American Psychiatric Publishing)|April 16, 2025
Symptom Severity and Treatment Needs Among Racial Groups Seeking Treatment at a Mood Outcomes ProgramJorge A Sanchez-Ruiz, Jason Straub, Peter P Zandi, et al.
Pageof 52

Showing results (201-210 of 518) with videos related to

Sort By:
Pageof 52
The Journal of Clinical Psychiatry|January 2, 2007
Incidence and time course of subsyndromal symptoms in patients with bipolar I disorder: an evaluation of 2 placebo-controlled maintenance trialsMark A Frye, Lakshmi N Yatham, Joseph R Calabrese, et al.
The Journal of Clinical Psychiatry|August 20, 2009
Mood stabilization and destabilization during acute and continuation phase treatment for bipolar I disorder with lamotrigine or placeboJoseph F Goldberg, Joseph R Calabrese, Benjamin R Saville, et al.
Elife|March 23, 2021
A visual pathway for skylight polarization processing in <i>Drosophila</i>Ben J Hardcastle, Jaison J Omoto, Pratyush Kandimalla, et al.
Journal of Clinical Psychopharmacology|January 13, 2025
Clinical and Demographic Predictors of Early Clozapine Discontinuation Across Mood and Psychotic DisordersMete Ercis, Kristin C Cole, Ross A Dierkhising, et al.
Biological Psychiatry|January 28, 2003
Low CSF somatostatin associated with response to nimodipine in patents with affective illnessMark A Frye, Peggy J Pazzaglia, Mark S George, et al.
Brain and Behavior|May 31, 2021
Self-report screening instruments differentiate bipolar disorder and borderline personality disorderBrian A Palmer, Mehak Pahwa, Jennifer R Geske, et al.
International Journal of Bipolar Disorders|October 5, 2019
Treatment of bipolar depression with supraphysiologic doses of levothyroxine: a randomized, placebo-controlled study of comorbid anxiety symptomsMaximilian Pilhatsch, Thomas J Stamm, Petra Stahl, et al.
Biological Psychiatry|June 5, 2007
Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorderJoseph F Goldberg, Charles L Bowden, Joseph R Calabrese, et al.
Journal of Psychiatric Research|July 10, 2023
Prevalence and outcomes of rapid cycling bipolar disorder: Mixed method systematic meta-reviewAlessandro Miola, Konstantinos N Fountoulakis, Ross J Baldessarini, et al.
Focus (American Psychiatric Publishing)|April 16, 2025
Symptom Severity and Treatment Needs Among Racial Groups Seeking Treatment at a Mood Outcomes ProgramJorge A Sanchez-Ruiz, Jason Straub, Peter P Zandi, et al.
Pageof 52